Skip to main content
VCbacked
Log inGet Started

Dunad Therapeutics

London, United Kingdom

Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies.

$24.0M raised
Nov 2021
Series A
BiotechnologyPharmaceutical

Top Investors

Epidarex CapitalNovartisBioGeneration Ventures

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Dunad Therapeutics

How much funding has Dunad Therapeutics raised?
Dunad Therapeutics has raised $24.0M in total funding. The most recent round was Series A. The last funding was announced in November 2021.
Who are Dunad Therapeutics's investors?
Dunad Therapeutics's investors include Epidarex Capital, Novartis, BioGeneration Ventures.
Where is Dunad Therapeutics headquartered?
Dunad Therapeutics is headquartered in London, United Kingdom.
What does Dunad Therapeutics do?
Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies.
What stage is Dunad Therapeutics at?
Dunad Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Dunad Therapeutics — Funding & Investors." VCBacked, November 2, 2021, https://www.vcbacked.co/company/dunad-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2021). Dunad Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/dunad-therapeutics
Wikipedia (cite web)
{{cite web |title=Dunad Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/dunad-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K